24 May 2013
Keywords: authorized, generics, increase, competition, following, reports, drug
Article | 10 July 2006
Following reports that US drug major Merck & Co had slashed the price of its cholesterol-lowering drug Zocor (simvastatin) to health ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 July 2006
24 July 2006
© 2013 thepharmaletter.com